Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma

1998720 citationsJournal Article

Authors

Y. M. Dennis Lo · Prince of Wales Hospital

N M Hjelm

Carrie Fidler · John Radcliffe Hospital

Ian L. Sargent · John Radcliffe Hospital

Michael Murphy · John Radcliffe Hospital

P. Chamberlain · John Radcliffe Hospital

Priscilla M.K. Poon

Christopher W.G. Redman

Abstract

Noninvasive fetal RhD genotyping can be performed rapidly and reliably with the use of maternal plasma beginning in the second trimester of pregnancy.

Topics & Keywords

Prenatal Screening and Diagnostics Fetal and Pediatric Neurological Disorders Blood groups and transfusion

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 339, Issue 24, pp. 1734-1738

DOI: 10.1056/nejm199812103392402

Field-Weighted Citation Impact: 46.23